| RRC ID |
74912
|
| 著者 |
Sakamoto A, Inoue H, Miyamoto S, Ito S, Soda Y, Tani K.
|
| タイトル |
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer.
|
| ジャーナル |
Sci Rep
|
| Abstract |
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Innovative treatment is required to improve overall survival rates for advanced NSCLC. Oncolytic virotherapy using enteroviruses has emerged as a promising anticancer strategy. To identify a novel, potent virotherapy with an improved safety profile, we assessed the oncolytic activity of 28 enteroviral strains and focused on coxsackievirus A11 (CVA11). CVA11 infection caused extensive oncolytic activity in all three of the examined human NSCLC cell lines, with high intercellular adhesion molecule-1 (ICAM-1) expression associated with greater CVA11-induced cytotoxicity. In vitro inhibition analysis using a pan-caspase inhibitor and western blot detection of cleaved poly (ADP-ribose) polymerase (PARP) indicated that apoptosis partly contributed to CVA11-driven cytotoxicity. CVA11 infection-induced immunogenic cell death in vitro was strongly suggested by substantial calreticulin expression and release of high mobility group box-1 protein (HMGB1). Moreover, in vivo treatment of human NSCLC xenografts with intratumoral CVA11 injection caused complete tumor regression in all treated mice, without significant weight loss. Our findings indicate that novel oncolytic virotherapy utilizing CVA11 may be less toxic and more effective than current treatments for human NSCLC, thus warranting further investigation in clinical trial settings, especially in combination with immunotherapy.
|
| 巻・号 |
13(1)
|
| ページ |
5924
|
| 公開日 |
2023-4-12
|
| DOI |
10.1038/s41598-023-33126-x
|
| PII |
10.1038/s41598-023-33126-x
|
| PMID |
37046036
|
| PMC |
PMC10097657
|
| MeSH |
Animals
Carcinoma, Non-Small-Cell Lung* / pathology
Cell Line, Tumor
Enterovirus*
Humans
Lung Neoplasms* / pathology
Mice
Oncolytic Virotherapy*
Oncolytic Viruses* / genetics
|
| IF |
3.998
|
| リソース情報 |
| ヒト・動物細胞 |
A549 |
